Discover ITM and its cancer candidate ITM-11 as it brings one of the first big wins the radiopharmaceutical sector awaits.

Discover the top-performing biotech stocks in 2024! From oncology to psychedelics some companies showed remarkable results.

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

The month of December 2024 saw a variety of biotech deals take place to advance therapies across different stages in ...